| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.21 | 0.003 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |